Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
This is a phase 3, open-label, randomized study to evaluate the safety and efficacy of the
Lilly/Alkermes inhaled insulin system compared to injected pre-meal insulin in non-smoking
patients with type 2 diabetes. Patients will be treated for 24 months with a 2-month
follow-up period.